Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Ascendis Pharma ADR
(NQ:
ASND
)
138.84
-0.66 (-0.47%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Ascendis Pharma ADR
< Previous
1
2
3
4
5
6
Next >
Recap: Ascendis Pharma Q3 Earnings
November 07, 2023
Via
Benzinga
Preview: Ascendis Pharma's Earnings
November 06, 2023
Via
Benzinga
The Latest Analyst Ratings for Ascendis Pharma
October 09, 2023
Via
Benzinga
Impact on BioMarin's Sentiment: Voxzogo's Triumph Clouded by Uncertainty
September 28, 2023
Raymond James initiated coverage on BioMarin Pharmaceuticals Inc (NASDAQ: BMRN) with a Market Perform rating, noting sparsity in
Via
Benzinga
The Latest Analyst Ratings for Ascendis Pharma
September 07, 2023
Via
Benzinga
Earnings Scheduled For September 5, 2023
September 05, 2023
Companies Reporting Before The Bell • Procaps Gr (NASDAQ:PROC) is likely to report earnings for its second quarter.
Via
Benzinga
Earnings Preview For Ascendis Pharma
September 04, 2023
Via
Benzinga
Analyst Expectations for Ascendis Pharma's Future
July 24, 2023
Via
Benzinga
Where Ascendis Pharma Stands With Analysts
June 20, 2023
Via
Benzinga
The Latest Analyst Ratings for Ascendis Pharma
June 01, 2023
Via
Benzinga
FDA Rejects Ascendis Pharma's TransCon PTH For Hypoparathyroidism
May 01, 2023
The FDA issued a complete response letter (CRL) for Ascendis Pharma A/S's
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
May 01, 2023
Via
Benzinga
Why Shares of Ascendis Pharma Are Climbing Monday
May 01, 2023
A critical response letter from the FDA means hope remains for the company's hyperthyroidism therapy candidate.
Via
The Motley Fool
US Stocks Rise; Norwegian Cruise Line Posts Q1 Results
May 01, 2023
U.S. stocks traded higher this morning, ahead of the Federal Reserve’s monetary policy meeting. Following the market opening Monday, the Dow traded up 0.15% to 34,147.97, while the NASDAQ inched up...
Via
Benzinga
IVERIC bio, Ascendis Pharma And Other Big Stocks Moving Higher In Monday's Pre-Market Session
May 01, 2023
U.S. stock futures traded mixed this morning. Here are some big stocks recording gains in today’s pre-market trading session. Apollomics, Inc. (NASDAQ: APLM) surged 58.4% to $7.35 in pre-market trading...
Via
Benzinga
Hedge Funds Fall Short: Underperforming Low-Cost S&P 500 ETF By 6% In 2023. Here's Why.
April 20, 2023
So far, 2023 has not started well for the hedge fund sector, as a common SPDR S&P 500 Trust ETF (ARCA: SPY) fared much better than the Global X Guru Index ETF (ARCA: GURU), a fund that invests in the...
Via
Benzinga
Why Ascendis Pharma Stock Is Crashing This Week
April 06, 2023
The FDA put a roadblock in the path to market for Ascendis' hypoparathyroidism drug.
Via
The Motley Fool
Analyst Ratings for Ascendis Pharma
April 03, 2023
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
April 12, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 5, 2023
April 05, 2023
Via
Benzinga
Nasdaq Down 80 Points; VirTra Shares Spike Higher
April 03, 2023
U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite dropping around 80 points on Monday. The Dow traded up 0.89% to 33,571.43 while the NASDAQ fell 0.66% to 12,142.07. The S&P...
Via
Benzinga
Why Ascendis Pharma Stock Is Plunging Today
April 03, 2023
A regulatory hiccup is weighing on the biopharma's shares today.
Via
The Motley Fool
Ascendis Pharma Flags Regulatory Delay In US For Its Hypoparathyroidism Candidate
April 03, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 4, 2023
April 04, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
April 03, 2023
Via
Benzinga
Dow Up Triple Digits As Second Quarter Kicks Off
April 03, 2023
The Dow Jones Industrial Average is up 146 points midday to kick off the second quarter, while the S&P 500 Index inches lower, and the Nasdaq Composite sits firmly in the red.
Via
Talk Markets
Why Heska Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session
April 03, 2023
Gainers Nogin, Inc. (NASDAQ: NOGN) shares surged 172.4% to $7.41. Guardforce AI Co., Limited (NASDAQ: GFAI) jumped 101% to $14.24 after climbing 50% on Friday.
Via
Benzinga
Crude Oil Jumps Over 6%; OncoSec Medical Shares Plummet
April 03, 2023
U.S. stocks traded mixed midway through trading, with the Nasdaq Composite dropping more than 100 points on Monday. The Dow traded up 0.58% to 33,468.38 while the NASDAQ fell 0.96% to 12,104.67. The...
Via
Benzinga
Tesla, NIO And Other Big Stocks Moving Lower On Monday
April 03, 2023
U.S. stocks traded mixed, with the Dow Jones gaining around 200 points on Monday. Here are some big stocks recording losses in today’s session.
Via
Benzinga
Ascendis Stock Plunges As FDA Identifies Deficiencies In Company's New Drug Application
April 03, 2023
The FDA decision prevents Ascendis from labeling and marketing the new drug application for TransCon PTH. ASND stock plunged
Via
Investor's Business Daily
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.